These findings align with previous reports that ICG/DOX@PLGA NPs, wrapped with anti-HER2 affibody-armed macrophage membranes, showed excellent HER2-targeting capabilities and enhanced the probability of contact between NPs and tumor cells [18]. This evidence concerns the gene ERBB2 and neoplasm.